Search results
Showing results for
Adjusting to daily life with social isolation and lockdown has its challenges and the dramatic situation that we find ourselves in because of the COVID-19 pandemic, means people with eating disorders are at risk of their disorder becoming more severe or relapsing.
SINAPPS2 Background & PPiP2 Recruitment Training Confirmation
The SINAPPS2 Trial is inviting people with acute psychosis symptom(s) and anti-neuronal membrane antibodies who have been identified through PPiP2 study to consent the trial and help testing the efficacy and safety of immunotherapy for antibody-associated psychosis.